Currently, there are 387.15M common shares owned by the public and among those 386.60M shares have been available to trade.
The company’s stock has a 5-day price change of 1.68% and -39.43% over the past three months. EIX shares are trading -34.67% year to date (YTD), with the 12-month market performance down to -22.63% lower. It has a 12-month low price of $49.06 and touched a high of $88.77 over the same period. EIX has an average intraday trading volume of 4.58 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.19%, -18.81%, and -31.85% respectively.
Institutional ownership of Edison International (NYSE: EIX) shares accounts for 90.01% of the company’s 387.15M shares outstanding.
It has a market capitalization of $20.19B and a beta (3y monthly) value of 0.89. The stock’s trailing 12-month PE ratio is 15.31, while the earnings-per-share (ttm) stands at $3.41. The company has a PEG of 1.84 and a Quick Ratio of 0.81 with the debt-to-equity ratio at 2.34. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.59% over the week and 3.42% over the month.
Analysts forecast that Edison International (EIX) will achieve an EPS of 1.1 for the current quarter, 1.26 for the next quarter and 5.68 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 1.05 while analysts give the company a high EPS estimate of 1.05. Comparatively, EPS for the current quarter was 1.28 a year ago. Earnings per share for the fiscal year are expected to increase by 4.05%, and 15.03% over the next financial year.
Looking at the support for the EIX, a number of firms have released research notes about the stock. UBS stated their Buy rating for the stock in a research note on February 18, 2025, with the firm’s price target at $69-$65. Guggenheim was of a view on January 23, 2025 that the stock is Neutral, while Ladenburg Thalmann gave the stock Neutral rating on January 15, 2025, issuing a price target of $56.50. Barclays on their part issued Overweight rating on January 02, 2025.
